These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy. Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002 [TBL] [Abstract][Full Text] [Related]
4. ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy. Rumiato E; Cavallin F; Boldrin E; Cagol M; Alfieri R; Basso D; Castoro C; Ancona E; Amadori A; Ruol A; Saggioro D Pharmacogenet Genomics; 2013 Nov; 23(11):597-604. PubMed ID: 23962907 [TBL] [Abstract][Full Text] [Related]
5. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Gal TJ; Huang WY; Chen C; Hayes RB; Schwartz SM Laryngoscope; 2005 Dec; 115(12):2221-31. PubMed ID: 16369171 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes. Páez D; Salazar J; Paré L; Pertriz L; Targarona E; del Rio E; Barnadas A; Marcuello E; Baiget M Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1319-27. PubMed ID: 21570215 [TBL] [Abstract][Full Text] [Related]
7. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Mangoni M; Bisanzi S; Carozzi F; Sani C; Biti G; Livi L; Barletta E; Costantini AS; Gorini G Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):52-8. PubMed ID: 20708344 [TBL] [Abstract][Full Text] [Related]
8. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Chang-Claude J; Popanda O; Tan XL; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Ambrosone CB Clin Cancer Res; 2005 Jul; 11(13):4802-9. PubMed ID: 16000577 [TBL] [Abstract][Full Text] [Related]
9. DNA repair gene polymorphisms at XRCC1, XRCC3, XPD, and OGG1 loci in Maharashtrian population of central India. Pramanik S; Devi S; Chowdhary S; Surendran ST; Krishnamurthi K; Chakrabarti T Chemosphere; 2011 Feb; 82(7):941-6. PubMed ID: 21183201 [TBL] [Abstract][Full Text] [Related]
10. The role of GSTM1, GSTT1, GSTP1, and OGG1 polymorphisms in type 2 diabetes mellitus risk: a case-control study in a Turkish population. Gönül N; Kadioglu E; Kocabaş NA; Ozkaya M; Karakaya AE; Karahalil B Gene; 2012 Aug; 505(1):121-7. PubMed ID: 22652274 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. Huang ZH; Hua D; Du X Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656 [TBL] [Abstract][Full Text] [Related]
12. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Batar B; Güven M; Bariş S; Celkan T; Yildiz I Leuk Res; 2009 Jun; 33(6):759-63. PubMed ID: 19101034 [TBL] [Abstract][Full Text] [Related]
13. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525 [TBL] [Abstract][Full Text] [Related]
15. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504 [TBL] [Abstract][Full Text] [Related]
16. The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays. Gdowicz-Klosok A; Widel M; Rzeszowska-Wolny J Mutat Res; 2013 Jul; 755(1):42-8. PubMed ID: 23669291 [TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Ramachandran S; Ramadas K; Hariharan R; Rejnish Kumar R; Radhakrishna Pillai M Oral Oncol; 2006 Apr; 42(4):350-62. PubMed ID: 16324877 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the DNA repair genes XPD and XRCC1 and the risk of age-related macular degeneration. Görgün E; Güven M; Unal M; Batar B; Güven GS; Yenerel M; Tatlipinar S; Seven M; Yüksel A Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4732-7. PubMed ID: 20375340 [TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]